How to Justify Reduced Testing Schedules Using Risk Assessments
Pharmaceutical companies increasingly seek to streamline stability programs without compromising product quality or regulatory compliance. Justifying reduced testing schedules using risk assessments has become a key component of Quality Risk Management (QRM), enabling optimized protocols aligned with ICH Q9 and Q1E. This article provides a how-to guide for designing reduced testing schedules with robust scientific…
Read More “How to Justify Reduced Testing Schedules Using Risk Assessments” »
